Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Peptide fragment
GABA analog; GABA potentiator, adenosine A1 ago...
B-Raf inhibitor.
Derivative of aloe-emodin, anthraquinone found ...
PDGFR inhibitor.
STING antagonist
ALK and Ros1 inhibitor, Trk antagonist.
Found in Colchicum; microtubule polymerization ...
STING agonist
Endogenous peptide, cleavage product of angiote...
Non-essential amino acid alcohol.
Semi-synthetic avermectin; GABA potentiator.
Peptide, cleavage product of proenkephalin; κO...
Curcumin derivative; DNMT1 and α-amylase inhib...
Peptide, binds heparin.
Cytarabine derivative, nucleoside (cytosine) an...
Sirtuin inhibitor and iron chelator.
Flavonoid found in various plant sources.
Diterpene found in brewed, unfiltered coffee; F...
Diterpene alkaloid found in Lagochilus.